207 related articles for article (PubMed ID: 36896570)
1. Alpha-1 antitrypsin deficiency: current therapy and emerging targets.
McElvaney OF; Fraughen DD; McElvaney OJ; Carroll TP; McElvaney NG
Expert Rev Respir Med; 2023 Mar; 17(3):191-202. PubMed ID: 36896570
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for alpha-1 antitrypsin deficiency: an update.
Pires Ferreira D; Gruntman AM; Flotte TR
Expert Opin Biol Ther; 2023 Mar; 23(3):283-291. PubMed ID: 36825473
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
[TBL] [Abstract][Full Text] [Related]
4. RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease.
Strnad P; San Martin J
Expert Opin Investig Drugs; 2023; 32(7):571-581. PubMed ID: 37470509
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in understanding and treating COPD related to α
Henao MP; Craig TJ
Expert Rev Respir Med; 2016 Dec; 10(12):1281-1294. PubMed ID: 27771979
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
7. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
[TBL] [Abstract][Full Text] [Related]
8. Advances in Alpha-1 Antitrypsin Gene Therapy.
Lorincz R; Curiel DT
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):560-570. PubMed ID: 32668173
[TBL] [Abstract][Full Text] [Related]
9. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
Mohanka M; Khemasuwan D; Stoller JK
Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
[TBL] [Abstract][Full Text] [Related]
10. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
Fregonese L; Stolk J
Orphanet J Rare Dis; 2008 Jun; 3():16. PubMed ID: 18565211
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
[TBL] [Abstract][Full Text] [Related]
12. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
[TBL] [Abstract][Full Text] [Related]
13. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-antitrypsin deficiency: forgotten etiology.
Kaplan A; Cosentino L
Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
[TBL] [Abstract][Full Text] [Related]
16. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
17. Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlook.
Henao MP; Craig TJ
Allergy Asthma Proc; 2017 Mar; 38(2):98-107. PubMed ID: 28234047
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
19. Introducing standards of the best medical practice for patients with inherited alpha-1-antitrypsin deficiency in Central Eastern Europe.
Valiulis A; Utkus A; Stukas R; Valiulis A; Siderius L;
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):107-14. PubMed ID: 24798601
[TBL] [Abstract][Full Text] [Related]
20. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
Belchamber KBR; Walker EM; Stockley RA; Sapey E
Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
